Abbott LaboratoriesvsNu Skin Enterprises

ABT and NUS stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$107.87

Value $187B

-0.62%
ABT's page

NUS

Nu Skin Enterprises, Inc.

$3.89

Value $187M

-3.47%
NUS's page

Abbott Laboratories (ABT) has a market value of $187B and Nu Skin Enterprises (NUS) $187M. Over the last year, with dividends, ABT moved -15.4% and NUS -58.1%. Dividend yield: ABT 2.34%, NUS 6.21%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$187B

    NUS$187M

    ABT is 1,001 times NUS

  • Revenue, 12 months

    ABT$48.2B

    NUS$1.3B

    ABT is 36 times NUS

  • Net income, 12 months

    ABT$4.7B

    NUS-$234M

  • Operating margin

    ABT13.8%

    NUS-2.0%

    15.8 points apart

  • ROIC

    ABT6.3%

    NUS-2.3%

    8.6 points apart

  • P/E

    ABT39.9

    NUS–

  • Dividend yield

    ABT2.3%

    NUS6.2%

    3.9 points apart

  • 5-year return

    ABT-8.0%

    NUS-90.0%

    82.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-8.0%

NUS-90.0%

5010020222023202420252026
Returns by period
PeriodABTWith dividendsNUSWith dividends
1 year since November 14, 2025-15.4%Price -17.4%-58.1%Price -59.6%
3 years since November 16, 2023+14.6%+4.6% a yearPrice +7.6%-75.7%-37.6% a yearPrice -78.1%
5 years since November 15, 2021-8.0%-1.6% a yearPrice -16.7%-90.0%-36.9% a yearPrice -91.6%
10 years since November 16, 2016+225.7%+12.5% a yearPrice +170.0%-90.1%-20.7% a yearPrice -92.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesNUSNu Skin Enterprises

Valuation

ABTNUS
Valuation
Price$107.87$3.89
Market value$187B$187M
Enterprise value (EV)$214B$232M
P/E39.9–
P/E, 5-year median33.717.7
P/B3.70.3
EV/EBIT32.2–
Free cash flow yield3.6%–

Results and growth

ABTNUS
Results and growth
Revenue, 12 months$48.2B$1.3B
Net income, 12 months$4.7B-$234M
Free cash flow, 12 months$6.8B-$26M
Earnings per share, 12 months$2.69-$4.85
Revenue growth, year on year5.7%-14.3%
Revenue growth a year, past+5.1%over 5 years-10.5%over 5 years
EPS growth a year, past+8.3%over 5 years-2.6%over 5 years

Margins and returns on capital

ABTNUS
Margins and returns on capital
Gross margin56.9%67.8%
Operating margin13.8%-2.0%
Net margin9.8%-17.7%
ROIC6.3%-2.3%
ROE9.1%-33.6%

Balance sheet

ABTNUS
Balance sheet
Cash$4.3B$167M
Total debt$31.2B$277M
Net debt / EBITDA3.31.8
Interest cover6.7×-1.8×

Dividends and buybacks

ABTNUS
Dividends and buybacks
Dividend yield2.3%6.2%
Dividend per share, 12 months$2.52$0.24
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%10.7%
Shareholder yield2.8%16.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or NUS

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or Nu Skin Enterprises?

By market value, Abbott Laboratories ($187B) is about 1,001.2 times Nu Skin Enterprises ($187M), at today's prices.

How did ABT and NUS stock do over the last 10 years?

Since November 16, 2016, ABT's price moved +170.0% and NUS's -92.8%. With dividends: ABT +225.7% (+12.5% a year), NUS -90.1% (-20.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or NUS?

The dividend yield at today's price is 2.34% for Abbott Laboratories and 6.21% for Nu Skin Enterprises. Over the last twelve months they paid $2.52 and $0.24 per share.

Which has the higher profit margins, Abbott Laboratories or Nu Skin Enterprises?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and -17.7% for Nu Skin Enterprises, and the operating margin 13.8% and -2.0%. Revenue was $48.2B and $1.3B.

Which is the better investment, Abbott Laboratories or Nu Skin Enterprises?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.